Impact of preexisting antinuclear antibodies on combined immunotherapy and chemotherapy in advanced non-small cell lung cancer patients

Morimoto, K; Yamada, T; Nakamura, R; Katayama, Y; Tanaka, S; Takumi, C; Hiraoka, N; Ogura, Y; Takeda, T; Onoi, K; Chihara, Y; Taniguchi, R; Yamada, T; Matsui, Y; Hiranuma, O; Morimoto, Y; Iwasaku, M; Kaneko, Y; Uchino, J; Takayama, K

Yamada, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pulm Med, Kamikyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.

MEDICAL ONCOLOGY, 2020; 37 (12):

Abstract

Combined immunotherapy and chemotherapy is a promising standard treatment in patients with advanced non-small cell lung cancer (NSCLC). This study aim......

Full Text Link